Your browser doesn't support javascript.
loading
An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancer.
Caponigro, F; Lacombe, D; Twelves, C; Bauer, J; Govaerts, A-S; Marréaud, S; Milano, A; Anthoney, A.
Affiliation
  • Caponigro F; Medical Oncology B, National Tumour Institute of Naples Fondazione G. Pascale Via M. Semmola, Naples, Italy. caponigrof@libero.it
Eur J Cancer ; 45(1): 48-55, 2009 Jan.
Article in En | MEDLINE | ID: mdl-18809314
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Boronic Acids / Colorectal Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 2009 Document type: Article Affiliation country: Italia Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Boronic Acids / Colorectal Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 2009 Document type: Article Affiliation country: Italia Country of publication: Reino Unido